🇺🇸 FDA
Patent

US 11712475

Sustained delivery formulations of risperidone compound

granted A61KA61K31/519A61K47/22

Quick answer

US patent 11712475 (Sustained delivery formulations of risperidone compound) held by Indivior UK Limited expires Mon Jul 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Indivior UK Limited
Grant date
Tue Aug 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/519, A61K47/22, A61K47/32, A61K47/34